Post-marketing Pharmacovigilance And Medical Information Market (2024 - 2030) Size, Share & Trends Analysis Report By Service (Spontaneous Reporting, Intensified ADR Reporting), By End Use, By Region, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation and Scope
                    1.2. Market Definitions
                    1.3. Research Methodology
                        1.3.1. Information Procurement
                        1.3.2. Information or Data Analysis
                        1.3.3. Market Formulation & Data Visualization
                        1.3.4. Data Validation & Publishing
                    1.4. Research Scope and Assumptions
                        1.4.1. List of Data Sources
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                    2.3. Competitive Insights
Chapter 3. Post-marketing Pharmacovigilance and Medical Information Market Variables, Trends, & Scope
                    3.1. Market Introduction/Lineage Outlook
                    3.2. Market Size and Growth Prospects (USD Billion)
                    3.3. Market Dynamics
                        3.3.1. Market Drivers Analysis
                        3.3.2. Market Restraints Analysis
                    3.4. Post-marketing Pharmacovigilance and Medical Information Market Analysis Tools
                        3.4.1. Porter’s Analysis
                            3.4.1.1. Bargaining power of the suppliers
                            3.4.1.2. Bargaining power of the buyers
                            3.4.1.3. Threats of substitution
                            3.4.1.4. Threats from new entrants
                            3.4.1.5. Competitive rivalry
                        3.4.2. PESTEL Analysis
                            3.4.2.1. Political landscape
                            3.4.2.2. Economic and Social landscape
                            3.4.2.3. Technological landscape
                            3.4.2.4. Environmental landscape
                            3.4.2.5. Legal landscape
Chapter 4. Post-marketing Pharmacovigilance and Medical Information Market: Service Estimates & Trend Analysis
                    4.1. Segment Dashboard
                    4.2. Post-Marketing Pharmacovigilance and Medical Information Market: Service Movement Analysis, 2023 & 2030 (USD Billion)
                    4.3. Spontaneous Reporting
                        4.3.1. Spontaneous Reporting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.4. Intensified ADR Reporting
                        4.4.1. Intensified ADR Reporting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.5. Targeted Spontaneous Reporting
                        4.5.1. Targeted Spontaneous Reporting Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.6. Cohort Event Monitoring
                        4.6.1. Cohort Event Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    4.7. EHR Mining
                        4.7.1. EHR Mining Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. Post-marketing Pharmacovigilance and Medical Information Market: End Use Estimates & Trend Analysis
                    5.1. Segment Dashboard
                    5.2. Post-marketing Pharmacovigilance and Medical Information Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
                    5.3. Hospitals
                        5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.4. Research Organizations
                        5.4.1. Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    5.5. Others
                        5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Post-marketing Pharmacovigilance and Medical Information Market: Regional Estimates & Trend Analysis
                    6.1. Post-marketing Pharmacovigilance and Medical Information Market Share, By Region, 2023 & 2030 (USD Billion)
                    6.2. North America
                        6.2.1. North America Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.2.2. U.S.
                            6.2.2.1. U.S. Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.2.3. Canada
                            6.2.3.1. Canada Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.2.4. Mexico
                            6.2.4.1. Mexico Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    6.3. Europe
                        6.3.1. Europe Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.3.2. UK
                            6.3.2.1. UK Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.3.3. Germany
                            6.3.3.1. Germany Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.3.4. France
                            6.3.4.1. France Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.3.5. Italy
                            6.3.5.1. Italy Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.3.6. Spain
                            6.3.6.1. Spain Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.3.7. Denmark
                            6.3.7.1. Denmark Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.3.8. Sweden
                            6.3.8.1. Sweden Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.3.9. Norway
                            6.3.9.1. Norway Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    6.4. Asia Pacific
                        6.4.1. Asia Pacific Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.4.2. China
                            6.4.2.1. China Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.4.3. Japan
                            6.4.3.1. Japan Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.4.4. India
                            6.4.4.1. India Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.4.5. South Korea
                            6.4.5.1. South Korea Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.4.6. Australia
                            6.4.6.1. Australia Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.4.7. Thailand
                            6.4.7.1. Thailand Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    6.5. Latin America
                        6.5.1. Latin America Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.5.2. Brazil
                            6.5.2.1. Brazil Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.5.3. Argentina
                            6.5.3.1. Argentina Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                    6.6. Middle East and Africa
                        6.6.1. Middle East and Africa Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.6.2. South Africa
                            6.6.2.1. South Africa Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.6.3. Saudi Arabia
                            6.6.3.1. Saudi Arabia Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.6.4. UAE
                            6.6.4.1. UAE Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
                        6.6.5. Kuwait
                            6.6.5.1. Kuwait Post-Marketing Pharmacovigilance and Medical Information Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis by Key Market Participants
                    7.2. Company Categorization
                    7.3. Company Heat Map Analysis
                    7.4. Company Profiles
                        7.4.1. IQVIA Inc
                            7.4.1.1. Participant’s Overview
                            7.4.1.2. Financial Performance
                            7.4.1.3. Product Benchmarking
                            7.4.1.4. Recent Developments/Strategic Initiatives
                        7.4.2. Parexel International (MA) Corporation
                            7.4.2.1. Participant’s Overview
                            7.4.2.2. Financial Performance
                            7.4.2.3. Product Benchmarking
                            7.4.2.4. Recent Developments/Strategic Initiatives
                        7.4.3. Laboratory Corporation of America Holdings
                            7.4.3.1. Participant’s Overview
                            7.4.3.2. Financial Performance
                            7.4.3.3. Product Benchmarking
                            7.4.3.4. Recent Developments/Strategic Initiatives
                        7.4.4. ICON plc
                            7.4.4.1. Participant’s Overview
                            7.4.4.2. Financial Performance
                            7.4.4.3. Product Benchmarking
                            7.4.4.4. Recent Developments/Strategic Initiatives
                        7.4.5. Syneos Health
                            7.4.5.1. Participant’s Overview
                            7.4.5.2. Financial Performance
                            7.4.5.3. Product Benchmarking
                            7.4.5.4. Recent Developments/Strategic Initiatives
                        7.4.6. Accenture
                            7.4.6.1. Participant’s Overview
                            7.4.6.2. Financial Performance
                            7.4.6.3. Product Benchmarking
                            7.4.6.4. Recent Developments/Strategic Initiatives
                        7.4.7. Cognizant
                            7.4.7.1. Participant’s Overview
                            7.4.7.2. Financial Performance
                            7.4.7.3. Product Benchmarking
                            7.4.7.4. Recent Developments/Strategic Initiatives
                        7.4.8. F. Hoffmann-La Roche Ltd
                            7.4.8.1. Participant’s Overview
                            7.4.8.2. Financial Performance
                            7.4.8.3. Product Benchmarking
                            7.4.8.4. Recent Developments/Strategic Initiatives
                        7.4.9. Sanofi
                            7.4.9.1. Participant’s Overview
                            7.4.9.2. Financial Performance
                            7.4.9.3. Product Benchmarking
                            7.4.9.4. Recent Developments/Strategic Initiatives
                        7.4.10. ArisGlobal
                            7.4.10.1. Participant’s Overview
                            7.4.10.2. Financial Performance
                            7.4.10.3. Product Benchmarking
                            7.4.10.4. Recent Developments/Strategic Initiatives
                        7.4.11. Ergomed Group
                            7.4.11.1. Participant’s Overview
                            7.4.11.2. Financial Performance
                            7.4.11.3. Product Benchmarking
                            7.4.11.4. Recent Developments/Strategic Initiatives
                        7.4.12. Medpace
                            7.4.12.1. Participant’s Overview
                            7.4.12.2. Financial Performance
                            7.4.12.3. Product Benchmarking
                            7.4.12.4. Recent Developments/Strategic Initiatives
                        7.4.13. IBM Corporation
                            7.4.13.1. Participant’s Overview
                            7.4.13.2. Financial Performance
                            7.4.13.3. Product Benchmarking
                            7.4.13.4. Recent Developments/Strategic Initiatives
                        7.4.14. Wipro
                            7.4.14.1. Participant’s Overview
                            7.4.14.2. Financial Performance
                            7.4.14.3. Product Benchmarking
                            7.4.14.4. Recent Developments/Strategic Initiatives
                        7.4.15. Capgemini
                            7.4.15.1. Participant’s Overview
                            7.4.15.2. Financial Performance
                            7.4.15.3. Product Benchmarking
                            7.4.15.4. Recent Developments/Strategic Initiatives